<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FT941-2414</title>
	</head>
	<body>
		<main>
			<p>940321 FT  21 MAR 94 / Company News (This Week): Wellcome - Other Companies The drugs group, which announces interim results on Thursday, was the worst performing FT-SE 100 stock of 1993. How well it does in 1994 will be influenced by the fortunes of Zovirax, its biggest selling drug - now facing a competitive threat from SmithKline Beecham's Famvir. First-half pre-tax profits are put at about Pounds 360m, against Pounds 324.6m.</p>
		</main>
</body></html>
            